Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Ideas
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Portfolio
News
Enterprise Solutions
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us
More
Plans
News
Trending
Portfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Ideas
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Tools
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us
Log Out
XLO
Stock Latest News
Company Announcements
Xilio Therapeutics Reports Q3 2024 Progress and Financials
5d ago
XLO
Premium
Company Announcements
Xilio Therapeutics Advances Cancer Drug and Financial Outlook
5d ago
8K
XLO
Premium
The Fly
Xilio Therapeutics announces initial data from Phase 1C trial for XTX101
5d ago
XLO
Premium
The Fly
Xilio Therapeutics expects cash to fund operations into Q2 of 2025
5d ago
XLO
Premium
The Fly
Xilio Therapeutics reports Q3 EPS (22c), consensus (25c)
5d ago
XLO
Premium
The Fly
Xilio Therapeutics reports Q2 EPS (24c) vs (70c) last year
3M ago
XLO
Premium
Company Announcements
Xilio Therapeutics Enhances Board with Two New Directors
5M ago
8K
XLO
Premium
The Fly
Xilio Therapeutics expects cash to fund operations into Q2 of 2025
6M ago
XLO
GILD
Premium
The Fly
Xilio Therapeutics reports Q1 EPS (62c) vs (83c) last year
6M ago
XLO
Premium
The Fly
Xilio Therapeutics files to sell 17.58M shares of common stock for holders
7M ago
XLO
Premium
The Fly
Fly Insider: Xilio, Aerovate among week’s notable insider trades
7M ago
XLO
ALDX
Premium
The Fly
Xilio Therapeutics reports Q4 EPS (64c), consensus (64c)
8M ago
XLO
Premium
Company Announcements
Xilio Therapeutics Strikes Lucrative Deal with Gilead Sciences
8M ago
8K
XLO
Premium
The Fly
Gilead sees FY24 EPS reduction of 3c-4c from Xilio Therapeutics deal
8M ago
XLO
GILD
Premium
The Fly
Xilio Therapeutics, Gilead announce exclusive license agreement for XTX301
8M ago
XLO
GILD
Premium
The Fly
Xilio Therapeutics announces $11.3M private placement equity financing
8M ago
XLO
Premium
The Fly
Xilio to get $43.5M upfront in pact with Gilead to develop/commercialize XTX301
8M ago
XLO
GILD
Premium
The Fly
Xilio Therapeutics sees advances across clinical pipeline, announces XTX30 data
10M ago
XLO
Premium
The Fly
Xilio Therapeutics initiates enrollment for Phase 1 combination trial of XTX101
11M ago
XLO
Premium
The Fly
Xilio Therapeutics reports Q3 EPS (61c), consensus (81c)
1y ago
XLO
Premium
The Fly
Xilio Therapeutics price target lowered to $6 from $9 at Guggenheim
1y ago
XLO
Premium
The Fly
Xilio reports initial monotherapy safety and anti-tumor activity data for XTX202
1y ago
XLO
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
